Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 4nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 4nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 5nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 7nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 10nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 10nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 13nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 13nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 14nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 14nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 16nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 23nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 24nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 24nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 25nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 26nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 28nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 28nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 29nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 29nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 29nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 30nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 31nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 33nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 34nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 35nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 35nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 36nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 39nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 39nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 40nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 40nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 42nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 42nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 42nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 43nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 44nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 44nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 45nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 45nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 46nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 46nMT: 2°CAssay Description:An MGAT2 inhibition test for test compounds was conducted in accordance with a partially modified version of the method described in John F. Lockwood...More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 49nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 51nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair
Target2-acylglycerol O-acyltransferase 2(Homo sapiens (Human))
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
TAISHO PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 52nMAssay Description:A test for MGAT2 inhibitory action of test compounds was conducted in accordance with a partially modified version of the method described in John F....More data for this Ligand-Target Pair